ICU Medical Financials

ICU Medical Inc

ICUINASDAQ

Trade with Public

$184.56

18.1910.93%

At close: Aug 7, 5:00 PM EST

$184.19

-0.37-0.2%

After Hours: 4:22 PM EST

PRO

Why Is It Moving?™:ICU Medical shares are trading higher after the company reported better-tha...

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 2 days ago

Click to view the webcast

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

ICU Medical Financials

ICU Medical (ICUI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.

Avi Kapoor

PRO
ICU Medical Raises FY2026 Adj EPS Guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 Est

ICU Medical (NASDAQ:ICUI) raises FY2026 Adj EPS guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 analyst estimate..

Benzinga Newsdesk

PRO
ICU Medical Raises FY2026 GAAP EPS Guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 Est

ICU Medical (NASDAQ:ICUI) raises FY2026 GAAP EPS guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 analyst estimate..

Benzinga Newsdesk

PRO
ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 by 24.08 percent. This is a 12.86 percent increase over earnings of $2.10 per share from the

Benzinga Newsdesk

PRO
ICU Medical Affirms FY2026 GAAP EPS Guidance of $1.03-$1.74 vs $1.73 Est

ICU Medical (NASDAQ:ICUI) affirms FY2026 GAAP EPS guidance from $1.03-$1.74 to $1.03-$1.74 vs $1.73 analyst estimate..

Benzinga Newsdesk

PRO
ICU Medical Affirms FY2026 Adj EPS Guidance of $7.75-$8.45 vs $8.09 Est

ICU Medical (NASDAQ:ICUI) affirms FY2026 Adj EPS guidance from $7.75-$8.45 to $7.75-$8.45 vs $8.09 analyst estimate..

Benzinga Newsdesk

Benzinga

Benzinga

ICU Medical Inc

ICU Medical Financials

Earnings & Guidance News

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

PROICU Medical Raises FY2026 Adj EPS Guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 Est

PROICU Medical Raises FY2026 GAAP EPS Guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 Est

PROICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate

PROICU Medical Affirms FY2026 GAAP EPS Guidance of $1.03-$1.74 vs $1.73 Est

PROICU Medical Affirms FY2026 Adj EPS Guidance of $7.75-$8.45 vs $8.09 Est

PRO
ICU Medical Raises FY2026 Adj EPS Guidance from $7.75-$8.45 to $8.60-$9.00 vs $8.16 Est

PRO
ICU Medical Raises FY2026 GAAP EPS Guidance from $1.03-$1.74 to $2.89-$3.29 vs $2.77 Est

PRO
ICU Medical Q2 Adj. EPS $2.37 Beats $1.91 Estimate, Sales $551.700M Beat $533.428M Estimate

PRO
ICU Medical Affirms FY2026 GAAP EPS Guidance of $1.03-$1.74 vs $1.73 Est

PRO
ICU Medical Affirms FY2026 Adj EPS Guidance of $7.75-$8.45 vs $8.09 Est